1. Market Research
  2. > Business Services
  3. > Research and Development Market Trends
  4. > Janssen Research & Development, LLC - Product Pipeline Review - 2013

Janssen Research & Development, LLC - Product Pipeline Review - 2013

  • August 2013
  • -
  • Global Markets Direct
  • -
  • 30 pages

Janssen Research & Development, LLC - Product Pipeline Review - 2013

Summary

Global Market Direct’s pharmaceuticals report, “Janssen Research & Development, LLC - Product Pipeline Review - 2013” provides data on the Janssen Research & Development, LLC’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Janssen Research & Development, LLC’s corporate website, SEC filings, investor presentations and featured press releases, both from Janssen Research & Development, LLC and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Janssen Research & Development, LLC - Brief Janssen Research & Development, LLC overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Janssen Research & Development, LLC human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Janssen Research & Development, LLC with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Janssen Research & Development, LLC’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Janssen Research & Development, LLC’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Janssen Research & Development, LLC in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Janssen Research & Development, LLC’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Janssen Research & Development, LLC.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Janssen Research & Development, LLC and identify potential opportunities in those areas.

Table Of Contents

Janssen Research and Development, LLC - Product Pipeline Review - 2013
Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Janssen Research and Development, LLC Snapshot 5
Janssen Research and Development, LLC Overview 5
Key Information 5
Key Facts 5
Janssen Research and Development, LLC - Research and Development Overview 6
Key Therapeutic Areas 6
Janssen Research and Development, LLC - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Janssen Research and Development, LLC - Pipeline Products Glance 11
Janssen Research and Development, LLC - Late Stage Pipeline 11
Janssen Research and Development, LLC Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Phase I Products/Combination Treatment Modalities 12
Janssen Research and Development, LLC - Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
Discovery Products/Combination Treatment Modalities 14
Janssen Research and Development, LLC - Drug Profiles 15
Drug For Smoking Cessation 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
esketamine 16
Product Description 16
Mechanism of Action 16
RandD Progress 16
JNJ-40346527 17
Product Description 17
Mechanism of Action 17
RandD Progress 17
JNJ-47910382 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
Stem Cell Therapy 19
Product Description 19
Mechanism of Action 19
RandD Progress 19
Janssen Research and Development, LLC - Pipeline Analysis 20
Janssen Research and Development, LLC - Pipeline Products by Therapeutic Class 20
Janssen Research and Development, LLC - Pipeline Products By Target 22
Janssen Research and Development, LLC - Pipeline Products by Route of Administration 23
Janssen Research and Development, LLC - Pipeline Products By Mechanism of Action 24
Janssen Research and Development, LLC - Dormant Projects 25
Janssen Research and Development, LLC - Discontinued Pipeline Products 26
Discontinued Pipeline Product Profiles 26
doripenem 26
Janssen Research and Development, LLC - Locations And Subsidiaries 27
Head Office 27
Other Locations and Subsidiaries 27
Appendix 29
Methodology 29
Coverage 29
Secondary Research 29
Primary Research 29
Expert Panel Validation 29
Contact Us 30
Disclaimer 30



List of Tables

Janssen Research and Development, LLC, Key Information 5
Janssen Research and Development, LLC, Key Facts 5
Janssen Research and Development, LLC - Pipeline by Indication, 2013 8
Janssen Research and Development, LLC - Pipeline by Stage of Development, 2013 9
Janssen Research and Development, LLC - Monotherapy Products in Pipeline, 2013 10
Janssen Research and Development, LLC - Phase II, 2013 11
Janssen Research and Development, LLC - Phase I, 2013 12
Janssen Research and Development, LLC - Preclinical, 2013 13
Janssen Research and Development, LLC - Discovery, 2013 14
Janssen Research and Development, LLC - Pipeline By Therapeutic Class, 2013 21
Janssen Research and Development, LLC - Pipeline By Target, 2013 22
Janssen Research and Development, LLC - Pipeline By Route of Administration, 2013 23
Janssen Research and Development, LLC - Pipeline Products By Mechanism of Action, 2013 24
Janssen Research and Development, LLC - Dormant Developmental Projects,2013 25
Janssen Research and Development, LLC - Discontinued Pipeline Products, 2013 26
Janssen Research and Development, LLC, Other Locations 27



List of Figures

Janssen Research and Development, LLC - Pipeline by Indication, 2013 7
Janssen Research and Development, LLC - Pipeline by Stage of Development, 2013 9
Janssen Research and Development, LLC - Monotherapy Products in Pipeline, 2013 10
Janssen Research and Development, LLC - Pipeline By Therapeutic Class, 2013 20
Janssen Research and Development, LLC - Pipeline By Route of Administration, 2013 23
Janssen Research and Development, LLC - Pipeline Products By Mechanism of Action, 2013 24



Companies Mentioned

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2016

Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2016’, provides in depth analysis on Integrin Alpha 7 (ITGA7) ...

Pulmonary Fibrosis - Pipeline Review, H2 2016

Pulmonary Fibrosis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Pulmonary Fibrosis - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Pulmonary Fibrosis - Pipeline Review, H2 2016’, provides an overview of the Pulmonary Fibrosis pipeline landscape. ...

Cognitive Impairment - Pipeline Review, H2 2016

Cognitive Impairment - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Cognitive Impairment - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H2 2016’, provides an overview of the Cognitive Impairment pipeline landscape. ...


ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.